ATE233083T1 - Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen - Google Patents

Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen

Info

Publication number
ATE233083T1
ATE233083T1 AT94928700T AT94928700T ATE233083T1 AT E233083 T1 ATE233083 T1 AT E233083T1 AT 94928700 T AT94928700 T AT 94928700T AT 94928700 T AT94928700 T AT 94928700T AT E233083 T1 ATE233083 T1 AT E233083T1
Authority
AT
Austria
Prior art keywords
applications
composition
well
viscoelastic material
physiological
Prior art date
Application number
AT94928700T
Other languages
English (en)
Inventor
Bradford C Webb
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE233083T1 publication Critical patent/ATE233083T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
AT94928700T 1993-04-30 1994-04-06 Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen ATE233083T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5582293A 1993-04-30 1993-04-30
PCT/US1994/003749 WO1994025004A1 (en) 1993-04-30 1994-04-06 Synthetic viscoelastic material for ophthalmic applications

Publications (1)

Publication Number Publication Date
ATE233083T1 true ATE233083T1 (de) 2003-03-15

Family

ID=22000374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928700T ATE233083T1 (de) 1993-04-30 1994-04-06 Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen

Country Status (12)

Country Link
US (2) US5422376A (de)
EP (1) EP0732913B1 (de)
JP (1) JP2976350B2 (de)
KR (1) KR100246016B1 (de)
AT (1) ATE233083T1 (de)
AU (1) AU681146B2 (de)
CA (1) CA2161774C (de)
DE (1) DE69432188T2 (de)
DK (1) DK0732913T3 (de)
ES (1) ES2192560T3 (de)
RU (1) RU2145882C1 (de)
WO (1) WO1994025004A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
AU4741001A (en) 2000-03-14 2001-09-24 Alcon Universal Ltd Viscoelastics for use in middle ear surgery
US20030086899A1 (en) * 2000-03-14 2003-05-08 Jafari Masoud R. Chondroitin sulfate containing viscoelastics for use in treating joints
RU2200519C2 (ru) * 2000-05-15 2003-03-20 Ченчик Александр Дмитриевич Способ газовой тампонады при проведении офтальмологических полостных операций
AU2000268609A1 (en) * 2000-09-14 2002-03-26 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
JP2004530452A (ja) * 2000-11-06 2004-10-07 アルコン,インコーポレイテッド 外科手術において使用するための非吸引性遷移粘弾性物質
US6756363B1 (en) 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
US7169755B2 (en) * 2000-12-20 2007-01-30 Alcon, Inc. Solution for removing cataracts via liquefracture
WO2003011257A1 (en) * 2001-08-01 2003-02-13 Jasjit Singh Composition and process the manufacture of soluble containers with improved gel-strength
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20120283232A9 (en) * 2003-11-12 2012-11-08 Zhengjun Wang Process for making a pharmaceutical composition
US20050215515A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo Viscoelastic composition, method of use and package
US20060159651A1 (en) * 2005-01-14 2006-07-20 Michael Colvard Gradient molecular weight viscoelastic solutions
RU2310327C1 (ru) * 2006-03-24 2007-11-20 Владимир Николаевич Канюков Способ консервации донорских тканей для офтальмохирургии
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
DE102009037514A1 (de) 2009-08-17 2011-03-10 Dirk-Henning Dr. Menz Wasserlösliche Polysaccharidether und ihre Verwendung
US8845624B2 (en) * 2010-06-25 2014-09-30 Alcon LexSx, Inc. Adaptive patient interface
JP2016501931A (ja) 2012-11-21 2016-01-21 ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション,インコーポレーテッドUniversity Of Louisville Research Foundation,Inc. 酸化的損傷を減じるための組成物および方法
US10500282B2 (en) * 2012-12-19 2019-12-10 Kashiv Biosciences, Llc Supersaturated stabilized nanoparticles for poorly soluble drugs
DE102014103512A1 (de) 2014-03-14 2015-09-17 Carl Zeiss Meditec Ag Injektor zur Injektion eines Operations-Hilfsfluids in ein Auge sowie Verfahren zum Erzeugen eines Operations-Hilfsfluids
EP3256136A4 (de) 2015-02-09 2018-11-21 University Of Louisville Research Foundation, Inc. Ophthalmische zusammensetzungen und verfahren zur reduzierung von oxidativen schäden einer augenlinse
WO2022172089A1 (en) * 2021-02-12 2022-08-18 I Optima Ltd. Compound, method and system for ophthalmic surgery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
JPH0657245B2 (ja) * 1986-05-14 1994-08-03 ト−メ−産業株式会社 眼科手術用粘弾性溶液
US4819617A (en) * 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
US4853374A (en) * 1987-06-09 1989-08-01 M.D.R. Group, Inc. Viscoelastic vitreous substitute with UV blocker
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5218107A (en) * 1991-12-30 1993-06-08 The Dow Chemical Company Removal of undesirable material from water-soluble cellulose ether aqueous solutions

Also Published As

Publication number Publication date
WO1994025004A1 (en) 1994-11-10
JPH09507469A (ja) 1997-07-29
DE69432188T2 (de) 2004-01-22
US5422376A (en) 1995-06-06
ES2192560T3 (es) 2003-10-16
USRE42243E1 (en) 2011-03-22
JP2976350B2 (ja) 1999-11-10
AU6700894A (en) 1994-11-21
DE69432188D1 (de) 2003-04-03
CA2161774C (en) 2000-01-04
KR100246016B1 (ko) 2000-04-01
AU681146B2 (en) 1997-08-21
CA2161774A1 (en) 1994-11-10
DK0732913T3 (da) 2003-06-16
EP0732913A1 (de) 1996-09-25
RU2145882C1 (ru) 2000-02-27
HK1019005A1 (en) 2000-01-14
EP0732913B1 (de) 2003-02-26

Similar Documents

Publication Publication Date Title
DE69432188D1 (de) Synthetisches Viskoseelastisches Material für physiologische Anwendungen wie für Ophtalmologische Anwendungen
US4303676A (en) Hyaluronate based compositions and cosmetic formulations containing same
CA1240929A (en) Chondroitin sulfate/sodium hyaluronate compositions
US4863907A (en) Crosslinked glycosaminoglycans and their use
IT1283911B1 (it) Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5631243A (en) Collagen-based viscoelastic solution for visco-surgery
ATE129411T1 (de) Natriumhyaluronat-zusammensetzung.
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
DE69522550D1 (de) Flüssiges ophthalmologisches abgabesystem mit verzögerter freisetzung
US6051560A (en) Chrondroitin sulfate/sodium hyaluronate composition
DK54390D0 (da) Okularcyklosporinpraeparat
NZ226171A (en) Gel formulation containing polypeptide growth factor
FI900629A0 (fi) Tvaerbundna hydrogeler och anvaendning av dessa som saorskydd.
RU95101032A (ru) Косметическая или дермофармацевтическая композиция и способ ее получения
BRPI0106913B8 (pt) composições transparentes de limpeza em barra que são eficazes e não são irritantes para os olhos
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
SE9401540D0 (sv) Munhygienkomposition
IT1263144B (it) Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
MX9701609A (es) Composicion espesada por un alquileter de polisacarido.
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
JPS6084225A (ja) 点眼剤
DK0474282T3 (da) Anvendelse af polysaccharider i præparater til sårbehandling
BR0115154A (pt) material viscoelástico transicional não-aspirante para uso em cirurgia
IT1254712B (it) Uso dell'acido ialuronico lubrificante di protesi oculari.
CA1140469A (en) Hyaluronate based compositions and cosmetic formulations containing same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties